Table 2 Univariate analysis to determine the predictors for residual hypoperfused segments.

Location of the thrombi^a

 Peripheral thrombus

78/87 (89.7%)

9/87 (10.3%)

 Proximal thrombus

92/125 (73.6%)

33/125 (26.4%)

Vascular patency^a

 Occlusive thrombus

101/127 (79.5%)

26/127 (20.4%)

 Non-occlusive thrombus

69/85 (81.2%)

16/85 (18.8%)

HU values of LPBV^b

9.156 ± 6.3262

9.469 ± 7.567

Age^b

64.1 ± 13.5

63.9 ± 12.0

Sex ratio (male: female)^a

65: 105

16: 26

Follow-up interval (days)^a

95.05 ± 127.6

55.02 ± 78.49

Heparin therapy (n = 142)^a

113/142 (79.6%)

29/142 (20.4%)

Warfarin therapy (n = 126)^a

105/126 (83.3%)

21/126 (16.7%)

DOAC (n = 83)^a

64/83 (77.1%)

19/83 (22.9%)

Thrombolytic therapy (n = 7)^a

3/7 (42.9%)

4/7 (57.1%)

IVC filter detention (n = 47)^a

33/47 (70.2%)

14/47 (29.8%)